- Home
- Publications
- Publication Search
- Publication Details
Title
GRP78 Mediates Cell Growth and Invasiveness in Endometrial Cancer
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 229, Issue 10, Pages 1417-1426
Publisher
Wiley
Online
2014-02-14
DOI
10.1002/jcp.24578
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
- (2012) B. M. Slomovitz et al. CLINICAL CANCER RESEARCH
- AKT inhibition mitigates GRP78 (glucose-regulated protein) expression and contribution to chemoresistance in endometrial cancers
- (2012) Michael J. Gray et al. INTERNATIONAL JOURNAL OF CANCER
- A murine monoclonal antibody directed against the carboxyl-terminal domain of GRP78 suppresses melanoma growth in mice
- (2012) Gustaaf G. de Ridder et al. MELANOMA RESEARCH
- Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting
- (2011) Min Ni et al. BIOCHEMICAL JOURNAL
- Cripto Regulates Hematopoietic Stem Cells as a Hypoxic-Niche-Related Factor through Cell Surface Receptor GRP78
- (2011) Kenichi Miharada et al. Cell Stem Cell
- CDH16/Ksp-Cadherin Is Expressed in the Developing Thyroid Gland and Is Strongly Down-Regulated in Thyroid Carcinomas
- (2011) Gaetano Calì et al. ENDOCRINOLOGY
- Endoplasmic reticulum stress is activated in endometrial adenocarcinoma
- (2011) Giuseppe Bifulco et al. GYNECOLOGIC ONCOLOGY
- New insights in endometrial carcinogenesis
- (2011) Giuseppina D'Andrilli et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Inhibition of NF-κB1 and NF-κB2 activation in prostate cancer cells treated with antibody against the carboxyl terminal domain of GRP78: Effect of p53 upregulation
- (2010) U.K. Misra et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ligation of cell surface GRP78 with antibody directed against the COOH-terminal domain of GRP78 suppresses Ras/MAPK and PI 3-kinase/AKT signaling while promoting caspase activation in human prostate cancer cells
- (2010) Uma K. Misra et al. CANCER BIOLOGY & THERAPY
- Ligation of Prostate Cancer Cell Surface GRP78 Activates a Proproliferative and Antiapoptotic Feedback Loop
- (2010) Uma K. Misra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpressing GRP78 influences Ca2+ handling and function of mitochondria in astrocytes after ischemia-like stress
- (2010) Yi-Bing Ouyang et al. MITOCHONDRION
- GRP78: A Multifunctional Receptor on the Cell Surface
- (2009) Mario Gonzalez–Gronow et al. ANTIOXIDANTS & REDOX SIGNALING
- Modulation of the unfolded protein response in prostate cancer cells by antibody-directed against the carboxyl-terminal domain of GRP78
- (2009) U. K. Misra et al. APOPTOSIS
- PFT-α inhibits antibody-induced activation of p53 and pro-apoptotic signaling in 1-LN prostate cancer cells
- (2009) U.K. Misra et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomib
- (2009) J. Kern et al. BLOOD
- Tamoxifen-Induced Adduct Formation and Cell Stress in Human Endometrial Glands
- (2009) H. Andersson et al. DRUG METABOLISM AND DISPOSITION
- Ligation of cancer cell surface GRP78 with antibodies directed against its COOH-terminal domain up-regulates p53 activity and promotes apoptosis
- (2009) U. K. Misra et al. MOLECULAR CANCER THERAPEUTICS
- Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas
- (2008) Hua-chuan Zheng et al. HUMAN PATHOLOGY
- Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium
- (2008) Y. Fu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now